AU2002214307A1 - T cell line and use thereof - Google Patents
T cell line and use thereofInfo
- Publication number
- AU2002214307A1 AU2002214307A1 AU2002214307A AU1430702A AU2002214307A1 AU 2002214307 A1 AU2002214307 A1 AU 2002214307A1 AU 2002214307 A AU2002214307 A AU 2002214307A AU 1430702 A AU1430702 A AU 1430702A AU 2002214307 A1 AU2002214307 A1 AU 2002214307A1
- Authority
- AU
- Australia
- Prior art keywords
- cell line
- cell
- line
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 210000001744 T-lymphocyte Anatomy 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- AIDS & HIV (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000350685 | 2000-11-17 | ||
| JP2000-350685 | 2000-11-17 | ||
| PCT/JP2001/010018 WO2002040648A1 (en) | 2000-11-17 | 2001-11-16 | T cell line and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002214307A1 true AU2002214307A1 (en) | 2002-05-27 |
Family
ID=18823870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002214307A Abandoned AU2002214307A1 (en) | 2000-11-17 | 2001-11-16 | T cell line and use thereof |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20040043380A1 (en) |
| EP (1) | EP1335019A1 (en) |
| AU (1) | AU2002214307A1 (en) |
| WO (1) | WO2002040648A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003063777A2 (en) * | 2002-01-25 | 2003-08-07 | Albany Medical College | Rapid phenotypic cell-based hiv assay |
| WO2005028669A1 (en) * | 2003-09-19 | 2005-03-31 | Tibotec Pharmaceuticals Ltd. | Time-of-addition assay for identifying anti-viral compounds |
| EP2807252B1 (en) | 2012-01-26 | 2017-05-10 | Life Technologies Corporation | Methods for increasing the infectivity of viruses |
-
2001
- 2001-11-16 WO PCT/JP2001/010018 patent/WO2002040648A1/en not_active Ceased
- 2001-11-16 EP EP01982814A patent/EP1335019A1/en not_active Withdrawn
- 2001-11-16 US US10/416,362 patent/US20040043380A1/en not_active Abandoned
- 2001-11-16 AU AU2002214307A patent/AU2002214307A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002040648A1 (en) | 2002-05-23 |
| EP1335019A1 (en) | 2003-08-13 |
| US20040043380A1 (en) | 2004-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002225681A1 (en) | Yeast-dentritic cell vaccines and uses thereof | |
| AU2001213236A1 (en) | Mini-cyclone biocollector and concentrator | |
| AU2002235128A1 (en) | Expression miniarrays and uses thereof | |
| AU2001243525A1 (en) | Battery | |
| AU3620600A (en) | Skin-marking devices and their use | |
| AU2001285409A1 (en) | Memory devices and methods for use therewith | |
| AU2001237996A1 (en) | Thermally and chemically treating cells | |
| AU2001240637A1 (en) | Novel imidazotriazinones and the use thereof | |
| AU2001264258A1 (en) | Nonwoven-fabric laminate and use thereof | |
| AU2002211717A1 (en) | Stresscopins and their uses | |
| AU2001261750A1 (en) | Laminate and its use | |
| AU2001287064A1 (en) | Battery | |
| AU6635800A (en) | Pyridomorphinans, thienomoprhinans and use thereof | |
| AU2001292936A1 (en) | Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines | |
| AU2001292047A1 (en) | Composition containing an azaphthalocyanine and use | |
| AU2841801A (en) | Triazolotriazinones and the use thereof | |
| AU7458201A (en) | Laminate and use thereof | |
| AU2001295185A1 (en) | Multiplexing-interleaving and demultiplexing-deinterleaving | |
| AU2001293074A1 (en) | Human liver cell line | |
| AU2001257430A1 (en) | Battery | |
| AU2001257429A1 (en) | Battery | |
| AU2002213329A1 (en) | Battery | |
| AU2000231564A1 (en) | Phosphororganic compounds and the use thereof | |
| AU4432001A (en) | Trityl-type compounds and their use | |
| AU2001252062A1 (en) | Steatosis-modulating factors and uses thereof |